IGMS - Here Are the 2 Best Biotech Stocks in This Multibillion-Dollar Industry
As the American Society of Hematology conference wrapped up, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discussed the best investments in the hematology space. In this video from Motley Fool Live, recorded on Dec. 14, Brian talks about why bluebird bio (NASDAQ: BLUE) is a well-rounded company in the space as it develops treatments for both traditional blood diseases and blood cancer. He also pitches IGM Biosciences (NASDAQ: IGMS) , an up-and-coming drugmaker developing bispecific antibodies to treat blood cancers.
For further details see:
Here Are the 2 Best Biotech Stocks in This Multibillion-Dollar Industry